Member Profile
Membership type: full
Tania Rivera Hernandez
Country of origin: Mexico Currently in: Mexico, Ciudad de Mexico General field of specialization: Biological Systems and Organisms-
Degrees
2013 Doctorate Other -
Current Research Activities
Other
Vaccine development for bacterial human pathogens. Microbial pathogenesis. Infectious diseases.
Publications resulting from Research:
Rivera-Hernandez T., Walker M. Humanized Plasminogen Mouse Model to Study Group A Streptococcus Invasive Disease. In: Proft T., Loh J. (eds) Group A Streptococcus. Methods in Molecular Biology, vol 2136. Humana, New York, NY, 2020.
Xu Z., Rivera-Hernandez T., Moyle P. Development of an Enzyme-Mediated, Site-Specific Method to Conjugate Toll-Like Receptor 2 Agonists onto Protein Antigens: Toward a Broadly Protective, Four Component, Group A Streptococcal Self-Adjuvanting Lipoprotein–Fusion Combination Vaccine. ACS Infectious Diseases, 6, 7, 1770–1782, 2020.
Rivera-Hernandez T., Rhyme M. S., Cork A. J., Jones S., Segui-Perez C., Brunner L., Richter J., Petrovsky N., Lawrenz M., Goldblatt D., Collin N., Walker M. J. Vaccine-Induced Th1-Type Response Protects against Invasive Group A Streptococcus Infection in the Absence of Opsonizing Antibodies. mBio 11 (2), 2020.
Rivera-Hernandez T., Carnathan D. G., Jones S., Cork A. J., Davies M. R., Moyle P., Toth I., Batzloff M. R., McCarthy J., Nizet V., Goldblatt D., Silvestri G., Walker M. J. An Experimental Group A Streptococcus Vaccine That Reduces Pharyngitis and Tonsillitis in a Nonhuman Primate Model. mBio 10 (2), 2019.
Rivera-Hernandez T., Pandey M., Henningham A., Cole J., Choudhury B., Cork A. J., Gillen C. M., Ghaffar K. A., West N. P., Silvestri G., Good M. F., Moyle P. M., Toth I., Nizet V., Batzloff M. R., Walker M. J. Differing efficacies of lead group A streptococcal vaccine candidates and full-length M protein in cutaneous and invasive disease models. mBio 7(3), 2016.
Barnett T.C., Cole J.N., Rivera‐Hernandez T., Henningham A., Paton J.C., Nizet V., Walker M.J. Streptococcal toxins: role in pathogenesis and disease. Cellular microbiology 17 (12), 2015.
Rivera-Hernandez T., Carnathan D. G., Moyle P., Toth I., West N. P., Young P. R., Silvestri G., Walker M. J. The contribution of non-human primate models to the development of human vaccines. Discovery Medicine 18(101), 2014.
Chuan, Y.P., Rivera-Hernandez, T., Wibowo, N., Connors, N.K.,Wu, Y., Hughes, F.K., Lua, L.H., Middelberg, A.P. Effects of pre-existing anti-carrier immunity and antigenic element multiplicity on efficacy of a modular virus-like particle vaccine. Biotechnology and Bioengineering 110 (9) 2013.
Rivera-Hernandez, T., Hartas, J., Wu, Y., Chuan, Y.P., Lua, L.H.L., Good, M., Batzloff, M.R., Middelberg, A.P.J. Self-adjuvanting modular virus-like particles for mucosal vaccination against group A Streptococcus (GAS). Vaccine 31 (15) 2013.
Middelberg, A.P.J., Rivera-Hernandez, T., Wibowo, N., Lua, L.H.L., Fan, Y., Magor, G., Chang, C., Chuan, Y.P., Good, M., Batzloff, M.R. A microbial platform for rapid and low-cost virus-like particle and capsomere vaccines. Vaccine 29 (41), September 2011, pp. 7154-7162.
Current profession
Current professional activities type:ResearchDevelopment of vaccine candidates against infections caused by bacterial pathogens such as group A Streptococcus and Salmonella enterica.
Workshop and Conference Attended
2012 Institut Pasteur, Paris France Vaccinology course2016 Australia Lorne Infection and Immunity Conference2017 Fiji 20th Lancefield International Symposium on Streptococci and Streptococcal Diseases2019 Birmingham, UK BactiVac Annual MeetingPresentation given
2016Evaluation of leading group A streptococcal vaccine candidates and full-length M protein in cutaneous and invasive murine models of disease.AustraliaEvent: Lorne Infection and Immunity Conference2017Efficacy of a non-M protein GAS vaccine in a primate model of pharyngitis and tonsillitisFijiEvent: 20th Lancefield International Symposium on Streptococci and Streptococcal Diseases -
Other Awards
Oct 2017Young Investigator AwardAward given as part of the 20th Lancefield International Symposium on Streptococci and Streptococcal Diseases, for the work presented at that event.Jun 2018Early Career Researcher AwardAward given by the Australian Society for Medical Research at the Queensland Awards for Health & Medical Research for the work carried out towards the development of a group A Streptococcus vaccine.Jan 2017National Researcher Level 1Award given by the Sistema Nacional de Investigadores in Mexico. Award is valid for three years and has been re-awarded for the 2020-2022 period.
